Results 181 to 190 of about 159,335 (341)

Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor [PDF]

, 2005
Iris Lee, Liqing Wang, Andrew D. Wells, Martin E. Dorf, Engin Özkaynak, Wayne W. Hancock   +5 more
openalex   +1 more source

Do all Foxp3+ Tregs require Foxp3 for suppression?

American Journal of Transplantation, 2022
openaire   +2 more sources

Neutrophils in cancer: At the crucial crossroads of anti‐tumor and pro‐tumor

Cancer Communications, EarlyView.
Abstract Neutrophils are important components of the immune system and play a key role in defending against pathogenic infections and responding to inflammatory cues, including cancer. Their dysregulation indicates potential disease risk factors. However, their functional importance in disease progression has often been underestimated due to their ...
Wenpeng Cai, Tao Fan, Chu Xiao, Ziqin Deng, Yixiao Liu, Chunxiang Li, Jie He   +6 more
wiley   +1 more source

Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD [PDF]

, 2005
Kathrin Rieger
openalex   +1 more source

Mucosal FOXP3 -Expressing CD4 ⁺ CD25 ^high Regulatory T Cells in Helicobacter pylori -Infected Patients

, 2004
Anna Lundgren, Erika Strömberg, Åsa Sjöling, Catharina Lindholm, Karin Enarsson, Anders Edebo, Erik L. Johnsson, Elisabeth Suri‐Payer, P. Larsson, Anna Rudin, Ann–Mari Svennerholm, Björn Lundin   +11 more
openalex   +1 more source

Developmental regulation of Foxp3 expression during ontogeny [PDF]

, 2005
Jason D. Fontenot, James Dooley, Andrew G. Farr, Alexander Y. Rudensky   +3 more
openalex   +1 more source

Bronchus-associated lymphoid tissue–resident Foxp3+ T lymphocytes prevent antibody-mediated lung rejection [PDF]

, 2019
Alexander S. Krupnick, Alice Y. Tong, Andrew E. Gelman, Ankit Bharat, Baddoura, Brian W. Wong, Chyi S. Hsieh, Daniel Kreisel, Francine L. Kelly, Hiemann, Hsi-Min Hsiao, Jason M. Gauthier, Jon H. Ritter, Li, Linh Vuong, Onyema, Ramsey R. Hachem, Ryuji Higashikubo, Satona Tanaka, Scott M. Palmer, Varun Puri, Vu Van, Wenjun Li, William M. Baldwin   +23 more
core   +2 more sources

Efficacy and safety of apremilast and phototherapy versus phototherapy only in psoriasis vulgaris

The Journal of Dermatology, Volume 49, Issue 12, Page 1211-1220, December 2022., 2022
Abstract Phototherapy and apremilast (oral phosphodiesterase‐4 inhibitor) are well‐known in the treatment of moderate to severe psoriasis vulgaris. However, current evidence on the efficacy and safety of their combination is not sufficient. This multicenter, randomized controlled study compared the efficacy and safety between phototherapy as ...
Akimichi Morita, Yukie Yamaguchi, Chiharu Tateishi, Kyoko Ikumi, Aya Yamamoto, Haruna Nishihara, Daisuke Hayashi, Yukihiko Watanabe, Yuko Watanabe, Ayano Maruyama, Koji Masuda, Daisuke Tsuruta, Norito Katoh   +12 more
wiley   +1 more source

CAQ Corner: Basic concepts of transplant immunology

, 2022
Liver Transplantation, EarlyView.
Amanda Cheung, Josh Levitsky
wiley   +1 more source

Impact of the combination of sintilimab and chemotherapy on the tumor and paratumor PD‐L1, IDO, TIM‐3, FOXP3+ and CD8 expressions in patients with advanced esophageal squamous cell carcinoma

Thoracic Cancer, Volume 13, Issue 23, Page 3284-3294, December 2022., 2022
The expression of PD‐L1, CD8+, FOXP3+, TIM‐3, and IDO in tumor, paratumor tissues, but not lymph nodes, was significantly affected by chemoimmunotherapy. Compared with patients without chemoimmunotherapy, the expression of CD8+ T cells, IDO, and PD‐L1 were significantly decreased in tumor and paratumor tissues after chemoimmunotherapy, while the ...
Shifa Zhang, Haibo Cai, Junjun Huang, Gongchao Wang   +3 more
wiley   +1 more source